US Patent

US8182838 — Dry powder composition comprising co-jet milled particles for pulmonary inhalation

Formulation · Assigned to Vectura Ltd · Expires 2028-10-20 · 2y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a dry powder composition made by co-jet milling particles for use in pulmonary inhalation.

USPTO Abstract

The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.

Drugs covered by this patent

Patent Metadata

Patent number
US8182838
Jurisdiction
US
Classification
Formulation
Expires
2028-10-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Vectura Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.